Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
OPTIMIZATION OF THE TREATMENT OF PHILADELPHIA-POSITIVE LEUKEMIA WITH ABL TYROSINE KINASE INHIBITOR IMATINIB

No-Receipt date 2011-01100 - 31/03/2011
No-Filing date 20110400762 - 31/03/2011
No-Granting date 3074621 - 31/03/2011
No-EPO application date 07842842.2 - 20/09/2007
No-EPO granting date 2068938 - 19/01/2011
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2011 - 12/04/2011
Expiration date 21/09/2027
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US826622 P22/09/2006/US
US828278 P05/10/2006/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/00
A61K 31/506
A61K 49/00
A61P 35/02

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
357596 NOVARTIS AG LICHTSTRASSE 354056 BASEL SWITZERLAND

Inventors
CodeFirstnameSurname
843769 GATHMANN, INSA
843770 MAHON, FRANCOIS-XAVIER
843771 MOLIMARD, MATHIEU
843772 PICARD, STEPHANE
843773 WANG, YANFENG

Representatives
CodeFirstnameSurnameAddressTownZip
956NIKOLAOSLYMPERISSTOURNARA 37ATHINA (ATTIKIS)10682

Contact
CodeFirstnameSurnameAddressTownZipCountry
2832NIKOLAOSLYMPERISSTOURNARA 37ATHINA (ATTIKIS)10682 GREECE

Owners History

Title Instruments
DateOperationDescreption
4/3/2015 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 03/2015 Αρ. Πρωτ. Γ.Δ. 286/3.4.2015

Payments history 7 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015